Effect of Hydrocortisone on Mortality and Organ Support in Patients With Severe COVID-19
Tóm tắt
Từ khóa
Tài liệu tham khảo
Siemieniuk, 2020, Drug treatments for COVID-19: living systematic review and network meta-analysis., BMJ, 370, m2980, 10.1136/bmj.m2980
Annane, 2019, Corticosteroids for treating sepsis in children and adults., Cochrane Database Syst Rev, 12
Ewald, 2015, Adjunctive corticosteroids for Pneumocystis jiroveci pneumonia in patients with HIV infection., Cochrane Database Syst Rev
Ye, 2020, Efficacy and safety of corticosteroids in COVID-19 based on evidence for COVID-19, other coronavirus infections, influenza, community-acquired pneumonia and acute respiratory distress syndrome: a systematic review and meta-analysis., CMAJ, 192, E756, 10.1503/cmaj.200645
Lansbury, 2020, Corticosteroids as adjunctive therapy in the treatment of influenza: an updated Cochrane systematic review and meta-analysis., Crit Care Med, 48, e98, 10.1097/CCM.0000000000004093
Li, 2020, Impact of corticosteroid therapy on outcomes of persons with SARS-CoV-2, SARS-CoV, or MERS-CoV infection: a systematic review and meta-analysis., Leukemia, 34, 1503, 10.1038/s41375-020-0848-3
Russell, 2020, Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury., Lancet, 395, 473, 10.1016/S0140-6736(20)30317-2
Alhazzani, 2020, Surviving Sepsis Campaign: guidelines on the management of critically ill adults with coronavirus disease 2019 (COVID-19)., Crit Care Med, 48, e440, 10.1097/CCM.0000000000004363
Chopra, 2020, Corticosteroid administration is associated with improved outcome in patients with severe acute respiratory syndrome coronavirus 2-related acute respiratory distress syndrome., Crit Care Explor, 2, 10.1097/CCE.0000000000000143
Fadel, Early short course corticosteroids in hospitalized patients with COVID-19., Clin Infect Dis
Brenner, 2020, Corticosteroids, but not TNF antagonists, are associated with adverse COVID-19 outcomes in patients with inflammatory bowel diseases: results from an international registry., Gastroenterology, 159, 481, 10.1053/j.gastro.2020.05.032
Horby, Dexamethasone in Hospitalized Patients with Covid-19 - Preliminary Report., N Engl J Med
Angus, 2020, The REMAP-CAP (Randomized Embedded Multifactorial Adaptive Platform for Community-acquired Pneumonia) Study: rationale and design., Ann Am Thorac Soc, 17, 879, 10.1513/AnnalsATS.202003-192SD
Angus, 2015, Fusing randomized trials with big data: the key to self-learning health care systems?, JAMA, 314, 767, 10.1001/jama.2015.7762
Laterre, 2019, Effect of selepressin vs placebo on ventilator- and vasopressor-free days in patients with septic shock: the SEPSIS-ACT randomized clinical trial., JAMA, 322, 1476, 10.1001/jama.2019.14607
WHO Working Group on the Clinical Characterisation and Management of COVID-19 infection, 2020, A minimal common outcome measure set for COVID-19 clinical research., Lancet Infect Dis, 20, e192, 10.1016/S1473-3099(20)30483-7
Beigel, Remdesivir for the treatment of Covid-19: preliminary report., N Engl J Med
Association between administration of systemic corticosteroids and mortality among critically ill patients with COVID-19: a meta-analysis., JAMA
Bittl, 2017, Bayesian analysis: a practical approach to interpret clinical trials and create clinical practice guidelines., Circ Cardiovasc Qual Outcomes, 10, 10.1161/CIRCOUTCOMES.117.003563
Quintana, 2017, Bayesian analysis: using prior information to interpret the results of clinical trials., JAMA, 318, 1605, 10.1001/jama.2017.15574
Johns Hopkins University of Medicine Coronavirus Resource Center.COVID-19 in the USA. Accessed July 30, 2020. https://coronavirus.jhu.edu/
China National Health Commission. Chinese clinical guidance for COVID-19 pneumonia diagnosis and treatment (7th edition). Updated March 16, 2020. Accessed August 3, 2020. http://kjfy.meetingchina.org/msite/news/show/cn/3337.html
World Health Organization. The WHO clinical management of COVID-19 interim guidance. Updated May 27, 2020. Accessed August 3, 2020. https://www.who.int/publications/i/item/clinical-management-of-covid-19